Exploring [ 11 C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson’s Disease Severity is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5P41EB024495-02
Resource for Molecular Imaging Agents in Precision Medicine
National Institutes of Health
Grant: 1R01AG066464-01
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
National Institutes of Health
Grant: 5U19AG033655-12
Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort
National Institutes of Health
Grant: 5P30AG066507-03
Johns Hopkins Alzheimer's Disease Research Center
NIA NIH HHS
Grant: P30 AG066507
NIBIB NIH HHS
Grant: P41 EB024495
NIA NIH HHS
Grant: R01 AG066464
NIA NIH HHS
Grant: U19 AG033655
Fields of Study
Keywords
Sustainable Development Goals